We determined genomewide associations with the presence of aortic-valve calcification (among 6942 participants) and mitral annular calcification (among 3795 participants), as detected by computed ...

The presence of valve calcification increases the odds of at least mild paravalvular regurgitation after transcatheter aortic valve replacement (TAVR), according to a study published in the August ...

The mechanisms leading to valve calcification were traditionally believed to be due to passive accumulation of hydroxyapatite mineral, but recent studies have shown active processes similar to those ...

There may be relationships between bone mineral density at different body locations and cardiac calcification. Sex-specific differences may exist in these relationships. Further research is needed to ...

Aortic root rupture that occurs during transcatheter aortic valve replacement (TAVR) using balloon-expandable prostheses carries a heightened risk of in-hospital adverse events but can be predicted by ...

New research from KL Krems challenges existing diagnostic standards for aortic stenosis, offering fresh insights into calcification patterns that are independent of sex. Krems, Austria – (March 12, ...

Please provide your email address to receive an email when new articles are posted on . Mitral annulus calcification may be an independent risk factor for all-cause mortality and was more common among ...

A genetic component is believed to play an important role in valvular heart disease, but the specific genes involved have not been identified. Now an interntional group of researchers has identified ...

ROCHESTER, Minn. — A retrospective review of more than 24,000 patients who underwent an EKG at Mayo Clinic finds that nearly one-quarter of the patients had mitral annulus calcification, a chronic ...

Ideally the transcatheter aortic prosthesis should restrain the native leaflets and relieve stenosis, without unnecessary impingement upon the aorta, left ventricle or outflow tract. [24] Issues ...

IRVINE, Calif., May 25, 2021 (GLOBE NEWSWIRE) -- JenaValve Technology, Inc., developer, and manufacturer of differentiated transcatheter aortic valve implantation (TAVI) systems (also referred to as ...